Cathepsin B & L Are Not Required for Ebola Virus Replication

PLoS Neglected Tropical Diseases

Volumn 6, Issue 12, 2012, Pages

  Marzi, Andrea ^a,b   Reinheckel, Thomas ^c   Feldmann, Heinz ^a,b,d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN A1; CATHEPSIN B; CATHEPSIN L; CELL SURFACE PROTEIN; N (3 PROPYLCARBAMOYLOXIRANE 2 CARBONYL) ISOLEUCYLPROLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMEMT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EBOLA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; VESICULAR STOMATITIS VIRUS; VIRUS ENTRY; VIRUS LOAD; VIRUS REPLICATION; WEIGHT REDUCTION;

ANIMALS; CATHEPSIN B; CATHEPSIN L; CELL LINE; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HOST-PATHOGEN INTERACTIONS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SURVIVAL ANALYSIS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84872039335     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001923     Document Type: Article

References (50)

1. Sanchez A, Geisbert TW, Feldmann H, (2006) Filoviridae: Marburg and Ebola viruses Fields Virology pp. 1409-1448.
2. Towner JS, Sealy TK, Khristova ML, Albarino CG, Conlan S, et al. (2008) Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog 4: e1000212.
3. Takada A, (2012) Filovirus tropism: cellular molecules for viral entry. Frontiers in Microbiology 3/00034.
4. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, et al. (2011) Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477: 340-343.
5. Cote M, Misasi J, Ren T, Bruchez A, Lee K, et al. (2011) Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477: 344-348.
6. Goldman SD, Krise JP, (2010) Niemann-Pick C1 functions independently of Niemann-Pick C2 in the initial stage of retrograde transport of membrane-impermeable lysosomal cargo. J Biol Chem 285: 4983-4994.
7. Tang Y, Leao IC, Coleman EM, Broughton RS, Hildreth JE, (2009) Deficiency of niemann-pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in Gag accumulation in late endosomal/lysosomal compartments. J Virol 83: 7982-7995.
8. Saeed MF, Kolokoltsov AA, Albrecht T, Davey RA, (2010) Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog 6: e1001110.
9. Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, et al. (2010) Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog 6: e1001121.
10. Aleksandrowicz P, Marzi A, Biedenkopf N, Beimforde N, Becker S, et al. (2011) Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J Infect Dis 204 Suppl 3: S957-967.
11. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM, (2005) Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308: 1643-1645.
12. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, et al. (2006) Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol 80: 4174-4178.
13. Kaletsky RL, Simmons G, Bates P, (2007) Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol 81: 13378-13384.
14. Sanchez A, (2007) Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J Infect Dis 196 Suppl 2: S251-258.
15. Rossi A, Deveraux Q, Turk B, Sali A, (2004) Comprehensive search for cysteine cathepsins in the human genome. Bio Chem 385: 363-372.
16. Barrett AJ, (1992) Cellular proteolysis. An overview. Annals of the New York Academy of Sciences 674: 1-15.
17. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, et al. (2000) Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 106: 1127-1137.
18. Halangk W, Lerch MM, Brandt-Nedelev B, Roth W, Ruthenbuerger M, et al. (2000) Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 106: 773-781.
19. Roth W, Deussing J, Botchkarev VA, Pauly-Evers M, Saftig P, et al. (2000) Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 14: 2075-2086.
20. Nakagawa T, Roth W, Wong P, Nelson A, Farr A, et al. (1998) Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280: 450-453.
21. Sevenich L, Pennacchio LA, Peters C, Reinheckel T, (2006) Human cathepsin L rescues the neurodegeneration and lethality in cathepsin B/L double-deficient mice. Biol Chem 387: 885-891.
22. Felbor U, Kessler B, Mothes W, Goebel HH, Ploegh HL, et al. (2002) Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci USA 99: 7883-7888.
23. Ebert DH, Deussing J, Peters C, Dermody TS, (2002) Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J Biol Chem 277: 24609-24617.
24. Chandran K, Nibert ML, (2003) Animal cell invasion by a large nonenveloped virus: reovirus delivers the goods. Trends Micro 11: 374-382.
25. Pager CT, Dutch RE, (2005) Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J Virol 79: 12714-12720.
26. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, et al. (2005) Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci USA 102: 11876-11881.
27. Diederich S, Sauerhering L, Weis M, Altmeppen H, Schaschke N, et al. (2012) Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosomal-recycling compartment. J Virol.
28. Neumann G, Feldmann H, Watanabe S, Lukashevich I, Kawaoka Y, (2002) Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. Journal of virology 76: 406-410.
29. Neumann G, Geisbert TW, Ebihara H, Geisbert JB, Daddario-DiCaprio KM, et al. (2007) Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates. Journal of virology 81: 2995-2998.
30. Bray M, (2001) The role of the Type I interferon response in the resistance of mice to filovirus infection. J Gen Virol 82: 1365-1373.
31. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. The AMerican Journal of Hygiene 27: 493-497.
32. Nakayama E, Yokoyama A, Miyamoto H, Igarashi M, Kishida N, et al. (2010) Enzyme-linked immunosorbent assay for the detection of filovirus species-specific antibodies. Clin Vaccine Immunol.
33. Marzi A, Ebihara H, Callison J, Groseth A, Williams KJ, et al. (2011) Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. J Infect Dis 204 Suppl 3: S1066-1074.
34. Wong AC, Sandesara RG, Mulherkar N, Whelan SP, Chandran K, (2010) A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry. J Virol 84: 163-175.
35. Martinez O, Johnson J, Manicassamy B, Rong L, Olinger GG, et al. (2010) Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cellular microbiology 12: 148-157.
36. Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J, (1999) A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 179 Suppl 1: S248-258.
37. Reiser J, Adair B, Reinheckel T, (2010) Specialized roles for cysteine cathepsins in health and disease. J Clin Invest 120: 3421-3431.
38. Misasi J, Chandran K, Yang JY, Considine B, Filone CM, et al. (2012) Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J Virol 86: 3284-3292.
39. Gnirss K, Kuhl A, Karsten C, Glowacka I, Bertram S, et al. (2012) Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression. Virology 424: 3-10.
40. Wilen CB, Tilton JC, Doms RW, (2012) Molecular Mechanisms of HIV entry. Adv Exp Med Biol 726: 223-242.
41. Albertini AA, Baquero E, Ferlin A, Gaudin Y, (2012) Molecular and cellular aspects of rhabdovirus entry. Viruses 4: 117-139.
42. Bertram S, Glowacka I, Muller MA, Lavender H, Gnirss K, et al. (2011) Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol 85: 13363-13372.
43. Glowacka I, Bertram S, Muller MA, Allen P, Soilleux E, et al. (2011) Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol 85: 4122-4134.
44. Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, et al. (2010) Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol 84: 12658-12664.
45. Shulla A, Heald-Sargent T, Subramanya G, Zhao J, Perlman S, et al. (2011) A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol 85: 873-882.
46. Asagiri M, Hirai T, Kunigami T, Kamano S, Gober HJ, et al. (2008) Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science 319: 624-627.
47. Matsumoto F, Saitoh S, Fukui R, Kobayashi T, Tanimura N, et al. (2008) Cathepsins are required for Toll-like receptor 9 responses. Biochem Biophys Res Commun 367: 693-699.
48. Ewald SE, Lee BL, Lau L, Wickliffe KE, Shi GP, et al. (2008) The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456: 658-662.
49. Park B, Brinkmann MM, Spooner E, Lee CC, Kim YM, et al. (2008) Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nature immunology 9: 1407-1414.
50. Ewald SE, Engel A, Lee J, Wang M, Bogyo M, et al. (2011) Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J Exp Med 208: 643-651.